✦ LIBER ✦

Natalizumab update: a story of benefit and risk

✍ Scribed by Laurie J. Barten; Douglas R. Allington; Kendra A. Procacci; Michael P. Rivey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The return of natalizumab: weighing bene

✍ Douglas Goodin 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 51 KB

PND1 A Risk-Benefit Analysis of Natalizu

✍ A.R. Walker; B. Deniz; S.T. Alexopoulos; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

The risks and benefits of hormone replac

✍ Hunt, Kate; Vessey, Martin 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 951 KB

Percept: A prospective multicenter obser

✍ Heesen, C.; Meuth, S.; Zingler, V.C.; Wernsdoerfer, C.; Koepke, S.; Kleiter, I.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Balancing risk and reward: The question

✍ Stephen L. Hauser; S. Claiborne Johnston 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

The risks! and benefits? of risk-benefit

✍ Stuart E Dreyfus 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 535 KB